Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study

BACKGROUND: The hypoglycemic effect of bezafibrate is well established, but administration to a large population of patients with diabetes has not been reported. We investigated glycemic control, relationship between lipid metabolism and HbA1c, and safety in diabetic patients treated with bezafibrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Teramoto, Tamio, Shirai, Kohji, Daida, Hiroyuki, Yamada, Nobuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342914/
https://www.ncbi.nlm.nih.gov/pubmed/22439599
http://dx.doi.org/10.1186/1475-2840-11-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342914/
https://www.ncbi.nlm.nih.gov/pubmed/22439599
http://dx.doi.org/10.1186/1475-2840-11-29

Ejemplares similares